The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing
Author: Patti Seymour, Senior Consultant | Tom Ransohoff, Principal Consultant Dawn M. Ecker, Consultant | Howard H. Levine, President and CEO
Tuesday, June 06, 2017
ORC International's report "Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing" explores the causes, consequences, and potential solutions to forecasting challenges specifically related to biopharmaceutical drug substance manufacturing. This analysis provides further insight and perspective on the key themes that emerge from the report and offers additional solutions to companies to better prepare for the inevitable forecast inaccuracies for biopharmaceuticals.
Please complete the short form below to download this whitepaper.